Please upgrade your browser.
Despite these horror stories, Congress is trying to create a similar agency right here in the United States.
Pfizer announced that important study results involving the company's leading anticancer agent, Sutent (sunitinib malate), as well as data examining an investigational agent, CP-751,871, will be presented at the 33rd European Society for Medical Oncology (ESMO) Congress in Stockholm, 12-16 September 2008.
AGS-003 to be tested in combination with sunitinib.
Earn $150 for participation.
The spiralling cost of drugs presents an unavoidable challenge.
The rumor seems to be going around that Pfizer (PFE) might be making a bid for Bayer (aka Bayer/Schering). That sounds ridiculous to me, and if Pfizer actually does such a thing, its management is even more starved for ideas than its nastiest critics could believe.
Novartis said on Tuesday that RAD001 or everolimus, which it plans to sell under the brand name Afinitor, had been accepted for fast review given the medicine's potential to help patients who fail to respond to standard therapy.
"The NHS is going to face meltdown just because of one disease, so we're going to have to re-structure things for the future, look at new ways of bringing money into the health service and that is a huge political challenge."
Jeffrey S. Toepel, 59, formerly of Green Bay, passed away in Mesa, Ariz., after a courageous battle with cancer
A memorial service was held in Mesa, Ariz. In lieu of flowers, donations can be made to the Kidney Cancer Association.
The Penn State chapter of Uplifting Athletes a nonprofit organization that raises awareness for prevention and treatment of rare diseases has generated more than $300,000 over the last six years for the Kidney Cancer Association.
|Powered by NeonCRM|